MS-1819 Completed Phase 2 Trials for Cystic Fibrosis of Pancreas / Cystic Fibrosis (CF) / Cystic Fibrosis Gastrointestinal Disease Treatment

Indications	Status	Purpose	Phase
DBCOND0127198 (Cystic Fibrosis of Pancreas) DBCOND0040212 (Cystic Fibrosis (CF)) DBCOND0125114 (Cystic Fibrosis Gastrointestinal Disease)	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT04302662	Phase 2 Combination Study With Escalating Doses of MS1819-SD on Top of a Stable Dose of PPEs	MS-1819 (DB15004)